lipolysis is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-05-27. Numbers and descriptions here follow the published literature rather than marketing material.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.
The peptide is frequently described as a growth hormone fragment, although it is chemically distinct from full-length hGH. AOD-9604 contains 16 amino acids and includes two cysteine residues that can form an intramolecular disulfide bond. In solution, this structural feature can influence folding, aggregation, and stability. Published descriptions sometimes call it hGH 176-191 or AOD9604, with spacing and capitalization varying. Such naming differences can complicate literature searches, database entries, and product verification.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
==== Phylogenetic motif discovery ==== Motifs have also been discovered by taking a phylogenetic approach and studying similar genes in different species. For example, by aligning the amino acid sequences specified by the GCM (glial cells missing) gene in human, mouse and D. melanogaster, Akiyama and others discovered a pattern which they called the GCM motif in 1996. It spans about 150 amino acid residues, and begins as follows:
Heseltine spent nine weeks in the ranks as a Guardsman before being sent for three months of officer training at Mons Officer Cadet School, Aldershot, alongside men from other regiments. He was a capable cadet, reaching the rank of Junior Under-Officer and graduating with an A-Grade, but he was not awarded the Sword of Honour or promoted to the rank of Senior Under-Officer, as it was felt his age had given him an unfair advantage over younger cadets. Throughout his training he had been troubled by an old ankle sprain, but he declined the offer of a medical discharge. He was commissioned as a second lieutenant on 11 June 1959. Heseltine was granted leave to contest the general election in October that year; according to Ian Josephs this had been his plan from the start. Afterward he applied on business grounds for exemption from return to the Army, in part because of difficulties caused by an employee's embezzlement, and partly including the need to sort out his late father's affairs, and was exempted from his remaining sixteen months of service. During the 1980s his habit of wearing a Guards regimental tie, sometimes incorrectly knotted with a red stripe on the neck, was the subject of much acerbic comment from military figures and from older MPs with distinguished war records. Crick estimated that he must have worn the tie on more days than he actually served in the Guards.
=== BASDAI === The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), developed in Bath (UK), is an index designed to detect the inflammatory burden of active disease. The BASDAI can help to establish a diagnosis of AS in the presence of other factors such as HLA-B27 positivity, persistent buttock pain which resolves with exercise, and X-ray or MRI-evident involvement of the sacroiliac joints. It can be easily calculated and accurately assesses the need for additional therapy; a person with AS with a score of four out of a possible 10 points while on adequate NSAID therapy is usually considered a good candidate for biologic therapy. The Bath Ankylosing Spondylitis Functional Index (BASFI) is a functional index which can accurately assess functional impairment due to the disease, as well as improvements following therapy. The BASFI is not usually used as a diagnostic tool, but rather to establish a baseline and subsequent response to therapy.
Sources: en.wikipedia.org
All CHO cell lines are deficient in proline synthesis. Also, CHO cells do not express the epidermal growth factor receptor (EGFR), which makes them ideal in the investigation of various EGFR mutations. Furthermore, Chinese hamster ovary cells are able to produce proteins with complex glycosylations, post-translational modifications (PTMs) similar to those produced in humans. They are easily growable in large-scale cultures and have great viability, which is why they are ideal for GMP protein production. Also, CHO cells are tolerant to variations in parameters, be it oxygen levels, pH-value, temperature or cell density. Having a very low chromosome number (2n=22) for a mammal, the Chinese hamster is also a good model for radiation cytogenetics and tissue culture. Being the first cell line to be used for recombinant pharmaceutical production, regulatory concerns were raised with respect to Endogenous Retroviral Sequences (ERS). CHO cells contain about 1000 of these sequences and some of them are able to direct the synthesis of Intracisternal A-type particles and C-type particles. Also, low expression of reverse transcriptase was observed. However the majority of ERS are defective (stop codons in all reading frames) and contain large deletions of a putative retroviral genome.
Np(V) or NpO+2 is green-blue in aqueous solution, in which it behaves as a strong Lewis acid. It is a stable ion and is the most common form of neptunium in aqueous solutions. Unlike its neighboring homologues UO+2 and PuO+2, NpO+2 does not spontaneously disproportionate except at very low pH and high concentration:
=== PPAR-alpha agonists === An endogenous compound, 7(S)-Hydroxydocosahexaenoic Acid (7(S)-HDHA), which is a docosanoid derivative of the omega-3 fatty acid DHA was isolated as an endogenous high affinity ligand for PPAR-alpha in the rat and mouse brain. The 7(S) enantiomer bound with micromolar affity to PPAR alpha with 10 fold higher affinity compared to the (R) enantiomer and could trigger dendritic activation. PPARα (alpha) is the main target of fibrate drugs, a class of amphipathic carboxylic acids (clofibrate, gemfibrozil, ciprofibrate, bezafibrate, pemafibrate and fenofibrate). They were originally indicated for dyslipidemia of cholesterol and more recently for disorders characterized by high triglycerides.
Sources: en.wikipedia.org
After this, the June Days uprising broke out, over the course of 24–26 June, when the eastern industrial quarter of Paris, led by the worker Louis Pujol, fought the western quarter, led by general Louis-Eugène Cavaignac, who had been appointed military dictator. The socialist party was defeated and afterwards its members were deported. But the republic had been discredited and had already become unpopular with both the peasants, who were exasperated by the new land tax of 45 centimes imposed in order to fill the empty treasury, and with the bourgeoisie, who were intimidated by the power of the revolutionary clubs and disadvantaged by the economic stagnation. By the "riots" of the June Days, the working classes were also alienated from it. The Duke of Wellington wrote at this time, "France needs a Napoleon! I cannot yet see him..." The granting of universal suffrage to a society with Imperialist sympathies would benefit reactionaries, which culminated in the election of Louis-Napoléon Bonaparte as president of the republic.
Somerton and Frome: The Liberal Democrats take Somerton and Frome, overturning a Conservative majority of 29.6%. 22–23 July – The most successful weekend for UK cinema-going since 2019 is reported, with Oppenheimer and Barbie taking £30m in their box office openings. 23 July – The Cabinet Office announces the launch of the Humanitarian Medal for emergency workers and humanitarian relief teams, such as charities, service personnel and health workers. 24 July Thousands of Britons begin arriving home from Greece, after being evacuated due to catastrophic wildfires in the region. Travel agency Thomas Cook promises to refund those who booked holidays. The Competition and Markets Authority announces an investigation into companies that offer quickie divorces and will writing. 26 July Oscar-winning actor Kevin Spacey is cleared of all charges at London's Southwark Crown Court. His trial had included nine charges, with seven counts of sexual assault against four men. The consultation process for the proposed closure of hundreds of ticket offices at train stations in England is extended until 1 September. Dame Alison Rose admits to being the source of an inaccurate BBC news report about Nigel Farage's Coutts bank account after discussing the matter with BBC business editor Simon Jack, something she describes as a "serious error of judgement". She subsequently resigns from her post early the next day. 27 July The Met Office publishes its State of the UK Climate 2022 report.
In this process, a ligand is immobilized on the dextran surface of the SPR crystal. Through a microflow system, a solution with the analyte is injected over the ligand-covered surface. The binding of the analyte to the ligand causes an increase in the SPR signal (expressed in response units, RU). Following the association time, a solution without the analyte (typically a buffer) is introduced into the microfluidics to initiate the dissociation of the bound complex between the ligand and analyte. As the analyte dissociates from the ligand, the SPR signal decreases. From these association ('on rate', ka) and dissociation rates ('off rate', kd), the equilibrium dissociation constant ('binding constant', KD) can be calculated. The detected SPR signal is a consequence of the electromagnetic 'coupling' of the incident light with the surface plasmon of the gold layer. This interaction is particularly sensitive to the characteristics of the layer at the gold–solution interface, which is usually just a few nanometers thick. When substances bind to the surface, it alters the way light is reflected, causing a change in the reflection angle, which can be measured as a signal in SPR experiments. One common application is measuring the kinetics of antibody-antigen interactions.
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
No, it is a synthetic peptide fragment corresponding to a small portion of hGH. It is not the full 191-amino-acid hormone and does not reproduce all of hGH's effects.